In this one year randomized, controlled multicenter study, the authors compared the efficacy of sensor-augmented pump therapy (insulin pump, plus an integrated continuous glucose sensor-Metronic Minimed Paradigm REAL-Time system) with a regimen of multiple daily injections in 485 patients (329 adults and 156 children) with poorly controlled T1DM.

Read the article